Sign In
Buy MRNA
$49.06
+3.42 (+7.49%)
At Close: Jun 03, 2026
Why Moderna Stock Is Sinking Today
12:29pm, Wednesday, 11'th Feb 2026
Moderna (MRNA) shares slid about 10% in U.S. premarket trading Wednesday after the U.S. Food and Drug Administration declined to review its application for seas
MRNA Down Nearly 10% as FDA Refuses to Review Influenza Vaccine BLA
11:45am, Wednesday, 11'th Feb 2026
Moderna shares sink 10% after FDA issues Refusal-to-File letter for its mRNA-1010 flu vaccine, citing trial design concerns despite no safety flags.
Moderna Stock Alert: - Kehoe Law Firm, P.C. Investigating Securities Claims on Behalf of Moderna Investors - MRNA
10:46am, Wednesday, 11'th Feb 2026
Philadelphia, Pennsylvania--(Newsfile Corp. - February 11, 2026) - Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf
Moderna's work developing seasonal vaccines is ‘risky' under current FDA, analyst says
10:44am, Wednesday, 11'th Feb 2026
The biotech company said the FDA won't review its flu vaccine, in the latest hit to mRNA development.
Stock Futures Jump on Strong January Jobs Report
09:20am, Wednesday, 11'th Feb 2026
Stock futures are higher this morning after strong jobs data
Moderna's investigational flu vaccine denied FDA review, shares drop
08:00am, Wednesday, 11'th Feb 2026
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) shares fell almost 6% after the drugmaker announced that the US Food and Drug Administration’s (FDA) Center for...
First Look: Jobs Data Looms; WBD-NFLX Fight, Moderna Setback
07:40am, Wednesday, 11'th Feb 2026
Stock News FDA refuses to file Moderna's flu shot: Moderna (MRNA) said the FDA issued a refusal-to-file letter for its mRNA flu vaccine application, citing tria
Breakfast News: First SaaS, Now Finance Hit By AI
07:30am, Wednesday, 11'th Feb 2026
AI makes move into tax planning, Shopify and Unity report this morning, and more
Moderna Stock Sinks. The FDA Delivers a Blow to Its New Flu Vaccine.
07:05am, Wednesday, 11'th Feb 2026
The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu vaccine.
Wall Street Breakfast Podcast: Amazon Adds BETA To Cart
06:24am, Wednesday, 11'th Feb 2026
Amazon (AMZN) acquires a 5.3% stake in BETA Technologies, sharply boosting BETA's premarket share price. Moderna (MRNA) faces an FDA refusal-to-file for its mRNA-1010 influenza vaccine, citing inadequ
Moderna shares fall after FDA refuses to review new flu vaccine
02:29am, Wednesday, 11'th Feb 2026
Moderna shares opened 14% lower in Frankfurt on Wednesday in low volume after the U.S. Food and Drug Administration refused to review the company's approval application for its influenza vaccine.
The company said the agency wouldn't review its application on the grounds that the study testing the shot wasn't sufficient.
Moderna says US FDA refuses to review its influenza vaccine
06:08pm, Tuesday, 10'th Feb 2026
Moderna said on Tuesday the U.S. Food and Drug Administration will not review its approval application for its influenza vaccine.
Moderna says FDA refuses to review its application for experimental flu shot
06:03pm, Tuesday, 10'th Feb 2026
The Food and Drug Administration refused to start a review of Moderna's application for its experimental flu shot, the company said. It's another sign of the Trump administration's influence on tighte
Moderna Plunges After FDA Rejects Its Messenger-RNA-Based Flu Shot
06:00pm, Tuesday, 10'th Feb 2026
The FDA rejected Moderna's experimental flu vaccine Tuesday in a move that proved to be a blow to recently hot Moderna stock.
